Gutfeld: This is the biggest story you aren’t hearing

Real Pain Real Talk with APDF – another talk with Pharmacist Steve Ariens

Back by popular demand is Steve Ariens, APDF’s pharmacist consultant! Host Kat Hatz asks “Pharmacist Steve” more of your listener-submitted questions about chronic pain, disability, and the government and media’s response to a healthcare crisis that affects tens of millions of Americans on a daily basis. Tune in to see if your question has been answered and to hear Steve weigh in on important topics that help pain patients and their loved ones advocate for their care. You can also find more resources on Steve’s website, www.PharmacistSteve.com. If you have a question that you’d like to have Steve answer, you can tag or DM Kat on TikTok @TheKatInTheHatz, submit an email to admin@4APDF.org, or make a comment of the Spotify feed.

WERE THEY NOT HUMANS TOO; ENJOYING THE GOODNESS OF SLAVERY??? AND THE HORRORS OF FREEDOM IN THE GREAT STATE DESANTISBURG

WERE THEY NOT HUMANS TOO

s

A MESSAGE FROM THE GREAT STATE OF DESANTISBURG: THE GOODNESS OF SLAVERY GATOR BAIT, DEHUMANIZATION, AND OTHER (FLORIDA) TRADITIONS, “CLIMBING JACOB’S LADDER” SOLDIERS OF THE CROSS

UNFIT TO SERVE: BRANDY MCMILLION DON’T BE FOOLED BY THE FACE OF INJUSTICE

Among the higher-profile cases McMillion worked on was the prosecution of Dr. Rajendra Bothra of Bloomfield Hills, who faced charges in an alleged $500 million healthcare fraud scheme. Bothra was acquitted last year after spending three years in jail before his trial. Bothra was found not guilty of more than 40 federal counts and his former employees, Ganiu Edu, David Lewis, and Christopher Russo, in what was considered one of the most significant losses for the U.S. Attorney’s Office in over ten years. The one-year anniversary of the acquittal is Thursday. President Joe Biden plans to nominate another Michigan prosecutor to the U.S. District Court for the Eastern District of Michigan, Brandy R. McMillion,

 

THE USELESS EATERS: AUSA BRANDY R. MCMILLION: A STORY THAT FORMS HER TREACHERY, MALIGNANT AMBITIONS, NEO-EUGENICS, HER SUB-HUMANIZATION OF DR. RAJENDRA BOTHRA, MD AND OTHER SUCCESSFUL INDIAN PHYSICIANS!!!: MCMILLION UNFIT TO SERVE

 

DEATH BY A THOUSAND LIES AND THE FRAUDULENT TESTIMONY OF DR.TOMTHY E. KING,MD A SO-CALLED DEA MEDICAL EXPERT

Timothy E. King, MD “The Rat King Mother of All Fraud” Dr. King’s assertion that prescriptions of opioids should be deemed illegitimate if there is no objective evidence of functional improvement among patients. This premise, however, fails to account for the inherently subjective nature of pain – a critical factor in assessing the effectiveness of pain management. It’s worth noting that expert witnesses bear a tremendous responsibility when providing testimony in legal proceedings. Their credibility can shape the course of a trial, impacting lives and reputations in profound ways.
Dr. King’s role in this case serves as a sobering reminder of the potential consequences of inaccurate or misleading testimony.

 

“THE GREAT KING RAT,” OF DECEPTION ( DR. TIMOTHY E. KING MD), AND HIS WAR ON NARCOTIC MEDICATIONS IN THE TREATMENT OF PAIN: THE AMERICAN AGONY: IN THE BEGINNING, THERE WAS CHARLES R. SZYMAN, MD

TIMOTHY E. KING, MD: DEATH BY FRAUD AND DECEPTION, BLOOD ON HIS HANDS, DEMISE AND SUICIDE OF DR. CHARLES R. SZYMAN, MD

Timothy E. King, MD “The Rat King Mother of All Fraud” Dr. King’s assertion that prescriptions of opioids should be deemed illegitimate if there is no objective evidence of functional improvement among patients. This premise, however, fails to account for the inherently subjective nature of pain – a critical factor in assessing the effectiveness of pain management.

TRAGEDY UNVEILS TANGLED WEB OF DECEIT: “THE GREAT KING RAT,” DR. TIMOTHY E. KING’S TESTIMONY HAUNTS ACCUSED PHYSICIAN’S DEMISE

Inspectors find more serious problems at Ohio CVS pharmacies

Inspectors find more serious problems at Ohio CVS pharmacies

https://ohiocapitaljournal.com/2023/08/25/inspectors-find-more-serious-problems-at-ohio-cvs-pharmacies/

From a lack of control over narcotics to expired drugs on the shelves, inspectors at the Ohio Board of Pharmacy have found more problems at what appear to be chronically understaffed CVS pharmacies.

The new inspection reports from four Ohio pharmacies are in addition to reports finding similar problems at nine others that the Capital Journal reported on in July. In those reports, inspectors described mass departures by frustrated, burnt-out employees who said they didn’t think they could do their jobs safely and didn’t feel supported by CVS management.

Several current and former CVS pharmacy employees made similar complaints to the Capital Journal and said that the corporation seemed to be more focused on maintaining profits than it was on protecting patients.

For its part, CVS maintains that it strives to uphold the highest standards of patient service and safety. 

“As we’ve previously stated, we’re working with the Board of Pharmacy to resolve allegations raised from prior inspections at select CVS Pharmacy locations, we have policies and procedures in place to support prescription safety, and we’re committed to ensuring there are appropriate levels of staffing and resources at our pharmacies,” spokeswoman Amy Thibault said in an email Friday.

But the pharmacy board seems skeptical. 

Earlier this month, it proposed sweeping new rules that were prompted in part by what it found in its inspections of Ohio CVS stores. An important one is aimed at limiting wait times for prescriptions to be filled to 72 hours after inspection reports found numerous 14-day waits and some that were as long as a month.

One of the newly released inspection reports details the unexplained loss last year of nearly 1,000 doses of controlled substances at CVS store No. 16660 in Rossford, a Toledo suburb. They include 499 doses of Alprazolam, also known as Xanax, and 275 doses of Hydrocodone and Oxycodone.

The report said that the loss of 413 Alprazolam tablets was discovered on Nov. 12, 2021, but not reported until Jan. 4, 2022, nearly two months later.

On April 14, an inspector spoke to CVS’s asset protection leader about the losses. That person said they “were due to operational error at the pharmacy. He did not know why the losses were reported months after discovery. He reported the losses to CVS’ regulatory office and the office later reported to the Board,” the report said.

CVS, which owns the largest pharmacy retail chain in the United States, has been accused of using other business units to cut drug reimbursements in order to drive smaller competitors to sell out to CVS. Regardless of whether that’s actually the case, CVS for the past five years has been buying up and closing its competitors and moving prescriptions at those pharmacies to existing CVS stores.

In 2021, CVS also announced that it would also close 900 of its own stores in the United States over the next three years and move those prescriptions to remaining CVS locations as well.

But as it has heaped loads of new work onto its remaining pharmacies, it’s unclear whether it’s added staffing to help deal with the extra work.

A Board of Pharmacy report dated Aug. 16 said that Store No. 6153 in Columbus “absorbed prescriptions from CVS No. 342 which closed in August 2022.”

It added that the consolidation increased the prescription workload by at least 63%.

“The pharmacy went from filling 2,500 to 2,700 prescriptions per week to filling 4,400 prescriptions the week ending October 15, 2022,” it said.

A Dec. 8, 2022 inspection found conditions consistent with under-staffing. 

  • “Drug shelves were dusty, cluttered, and overflowing.”
  • “Pharmacy aisles were lined with stock bottles and trash (prescription inserts, foils, bits of paper, and loose pills).”
  • “There were 1,372 prescriptions in the work queue. The pharmacy dispenses an average of 700 prescriptions per day. The pharmacy was five days behind in the work queue.”

Thibault, the CVS spokeswoman, didn’t answer directly when asked whether the store added staff after it absorbed 63% more prescriptions from store No. 342. Similarly, the company’s spokespeople wouldn’t respond directly to earlier employee claims that they’re frequently told to cut hours even when employees are available and that district and regional managers receive bonuses based in part on keeping down labor costs.

Another of the reports released last week indicates similar cluttered, dirty conditions that could be related to under-staffing — this time at CVS store No. 6183 in Springfield. It also underscored how high turnover that is often associated with under-staffing can lead to the lack of controls over dangerous drugs.

During an inspection on Feb. 1, inspectors found that an inventory of controlled substances hadn’t been conducted since the previous April. That was the case even though there was a change of “Responsible Person,” or head pharmacist, in December and one was required to be done then.

A former CVS pharmacist last month told the Capital Journal that the lack of such controls — along with erratic double-checks called “cycle counts” — could allow narcotics to disappear from pharmacy shelves in a way that’s impossible to trace.

Yet another inspection report released last week details further problems likely associated with under-staffing at CVS store No. 6086 in Lebanon.

On Sept. 29, 2022, inspectors found “multiple expired drugs, including Colesevelam hydrochloride 626mg, armour thyroid 2 grain tablets, quinapril 40mg tablets, and quetiapine 200mg tablets, were in the active drug stock. They had expired between June 1, 2022 and August 30, 2022.”

After a subsequent inspection, they told the pharmacist in charge, “On or about October 20, 2022, you dispensed expired heparin 5000u/mL injections to Patient A.B. Patient A.B. administered one dose of the expired heparin 5000u/mL injection.”

Heparin is a blood thinner and if it’s expired, it can put an unsuspecting patient at risk by being less effective. Even so, a follow-up visit on Nov. 7, 2022 indicated that the problem with expired drugs persisted.

“Multiple expired drugs, including creams and ointments, were in the active drug stock,” the report said. “They had expired between August 2022 and October 2022.”

It’s not only CVS that seems reluctant to staff pharmacies at adequate levels. Opinion polling submitted by the Board of Pharmacy along with its proposed rule changes suggests that it’s a problem among the big chains, with their obsession with profits and relentless cost-cutting.

One was a 2021 survey asking Ohio pharmacists whether they agreed with the statement, “I feel that the workload-to-staff ratio allows me to provide for patients in a safe manner.” 

Almost 90% of those working for large chains responded that they didn’t have enough staff to keep patients safe. By contrast, almost three quarters of small-chain and independent pharmacists said they were adequately staffed to protect patients.

 

Heads up on the Presidential candidates

I am watching the Republican Presidential debates and Asa Hutchinson undefined just stated that he was former HEAD OF DRUG ENFORCEMENT ADMINISTRATION Under the George W Bush (43) administration

https://en.wikipedia.org/wiki/Asa_Hutchinson

When Ron DeSantis ran for Governor of FL in 2018 and the person running for Attorney General was married to a DEA AGENT. Of course, apparently I did not reach enough people or none paid attention, because she got elected.

TIMOTHY E. KING, MD AND “THE RISE OF NEO-EUGENICS” (MINDSET OF A SERIAL KILLER, MINDSET OF A MENGELE) MEDICAL COMMUNITY DEMANDS CONGRESSIONAL INVESTIGATION

Repeatedly appearing as an expert witness for the prosecution in the Eastern District, Dr. King’s biased and misleading statements raised concerns about potential conflicts of interest. It is argued that he operates as a medical fig leaf for prosecutors, who use his testimony to support their narrative on opioid use, often disregarding differing medical opinions.

TIMOTHY E. KING, MD, DEFRAUDING TAXPAYERS OF $BILLIONS, AND “THE RISE OF NEO-EUGENICS” (MINDSET OF A SERIAL KILLER, MINDSET OF A MENGELE) MEDICAL COMMUNITY DEMANDS CONGRESSIONAL INVESTIGATION

CVS stock plunges after Blue Shield of California drops retailer’s pharmacy services to save on drug costs

CVS stock plunges after Blue Shield of California drops retailer’s pharmacy services to save on drug costs

https://www.msn.com/en-us/money/companies/cvs-stock-plunges-after-blue-shield-of-california-drops-retailer-s-pharmacy-services-to-save-on-drug-costs/ar-AA1fp04L

Shares of CVS Health plunged 9% on Thursday after Blue Shield of California said it will drop the company’s pharmacy benefit management services and instead partner with Mark Cuban’s Cost Plus Drugs company and Amazon Pharmacy to save on drug costs for its nearly 5 million members. 

The announcement hints at the potential for health insurers to abandon the traditional pharmacy benefit manager, or PBM, system and sent shares of other companies that offer PBM services lower.

Cigna and UnitedHealth Group dropped about 7% and 1%, respectively. 

PBMs maintain lists of drugs covered by health insurance plans and negotiate drug discounts with manufacturers. But they have recently come under scrutiny from lawmakers for their role in inflating drug prices and causing health-care costs to skyrocket. 

CVS Health’s Caremark has been Blue Shield’s PBM partner for more than 15 years. 

Blue Shield will now work with five different companies to provide “convenient, transparent access to medications while lowering costs.”

Blue Shield CEO Paul Markovich said the plan, which is scheduled to fully launch in 2025, could save the company up to $500 million annually. 

Amazon Pharmacy will offer at-home drug delivery. Cuban’s Cost Plus Drug Company will provide access to low-cost medications through retail pharmacies. Another company, Abarca Health, will process drug claims.

Blue Shield will retain CVS Caremark for its specialty pharmacy services, which provide specialized therapies and counseling to patients suffering from complex disorders. 

“We look forward to providing care for Blue Shield of California’s members who require complex, specialty medications — as we have for nearly two decades,” said Michael DeAngelis, a spokesman for CVS Health, in a statement to CNBC.

Still, the loss of Blue Shield’s PBM partnership is another blow to Caremark, which is also set to lose a contract with Centene next year.